Human papillomavirus in head and neck cancer (literature review)
https://doi.org/10.17650/2222-1468-2019-9-2-43-52
Abstract
This review is devoted to assessing the prevalence of human papillomavirus (HPV) in head and neck tumors (HNC). HPV is recognized as the etiological factor of cervical cancer, but it may be involved in other tumors progression. Of the 28 studies presented, 6 studies showed a low incidence of HPV in HNC tissue (1.6—6.2 %).
Most often, HPV was detected in Singapore (90.6 %), Japan (100 %) and France (94.7 %). Most often found 16 types of virus (82 %) and 18 types (43 %). Low-grade HPV type 11 was most often observed in the Russian Federation (19 %). The frequency of occurrence of HPV in HNC varies, which raises the question about impact HPV and co-infection in HNC progression. It makes further research in this area relevant and promising.
About the Authors
A. M. Pevzner
Cancer Research Institute, Tomsk National Research Medical Center of the RAS
Russian Federation
Russian Federation
5 Kooperativny Lane, Tomsk 634009
M. M. Tsyganov
Cancer Research Institute, Tomsk National Research Medical Center of the RAS
Russian Federation
Russian Federation
5 Kooperativny Lane, Tomsk 634009
M. K. Ibragimova
Cancer Research Institute, Tomsk National Research Medical Center of the RAS
Russian Federation
Russian Federation
5 Kooperativny Lane, Tomsk 634009
N. V. Litvyakov
Cancer Research Institute, Tomsk National Research Medical Center of the RAS
Russian Federation
Russian Federation
5 Kooperativny Lane, Tomsk 634009
References
1. Syrjanen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol 2005;32 Suppl 1:S59—66. DOI: 10.1016/j.jcv.2004.11.017.
2. Ferlay J., Soerjomataram I., Dikshit R. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136(5):359-86. DOI: 10.1002/ijc.29210.
3. Пачес А.И. Опухоли головы и шеи. М.: Медицина, 2009. С. 333-334. [Paches A.I. Head and neck tumors. Moscow: Meditsina, 1983. Pp. 333-334. (In Russ.)].
4. Ridge J.A., Glisson B.S., Lango M.N., Feigenberg S. Head and neck tumors. In: Cancer management: a multidisciplinary approach. Ed. by R. Pazdur, L.D. Wagman, K.A. Camphausen, WJ. Hoskins. 11th edn. London: CMP, 2008. Pp. 369-408.
5. Gillison M.L., Chaturvedi A.K., Anderson W.F., Fakhry C. Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma. J Clin Oncol 2015;33(29):3235—42. DOI: 10.1200/JCO.2015.61.6995.
6. Turunen A., Rautava J., Grenman R. et al. Epstein-Barr virus (EBV)-encoded small RNAs (EBERs) associated with poor prognosis of head and neck carcinomas. Oncotarget 2017;8(16):27328-38. DOI: 10.18632/oncotarget.16033.
7. De Martel C., Ferlay J., Franceschi S. et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012;13(6):607—15. DOI: 10.1016/S1470-2045(12)70137-7.
8. Dayyani F., Etzel C.J., Liu M. et al. Metaanalysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head Neck Oncol 2010;2:15. DOI: 10.1186/1758-3284-2-15.
9. Mehanna H., Beech T., Nicholson T. et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer — systematic review and meta-analysis of trends by time and region. Head Neck 2013;35(5):747—55. DOI: 10.1002/hed.22015.
10. Termine N., Panzarella V., Falaschini S. et al. HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis(1988—2007). Ann Oncol 2008;19(10):1681—90. DOI: 10.1093/annonc/mdn372.
11. D’Souza G., Kreimer A.R., Viscidi R. et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356(19):1944—56. DOI: 10.1056/NEJMoa065497.
12. Smeets D., Ertmer K., Braunschweig T., Bolotin M. HPV in squamous epithelial lesions of the head and neck: different affection of different tumors. Opukholi golovy i shei = Head and Neck Tumors 2011;(1):61—5. (In Russ.).
13. Svetickiy P.V., Zlatnik E.Y., Zykova T.A. et al. For cancer of the mouth with regard association with the Epstein—Barr virus, human papillomavirus and the levels of certain cytokines. Mezhdunarodny zhurnal prikladnykh i fundamentalnykh issledovaniy = International Journal of Applied and Fundamental Research 2014;(11-1):120—2. (In Russ.).
14. Gutkovskaya E.A., Smolyakova R.M., Zukovec A.G., Franckevich T.V. Human papillomaviruses and Epstein—Barr virus in cancer of the oral cavity, pharynx and larynx: genetic characteristicsand incidence of determination. Onkologichesky zhurnal = Cancer Journal 2012;6(1):71—4. (In Russ.).
15. Бычков В.А., Уразова Л.Н., Никитина Е.Г. и др. Папилломавирусная инфекция и прогрессия опухолей головы и шеи. Инфекция и иммунитет 2014;4(2):162—6. [Bychkov V.A., Urazova L.N., Nikitina E.G. et al. Human papillomavirus infection and head and neck cancer progression. Infektsiya i immunitet = Russian Journal of Infection and Immunity 2014;4(2):162—6. (In Russ.)].
16. Acharya S., Ekalaksananan T., Vatanasapt P. et al. Association of Epstein—Barr virus infection with oral squamous cell carcinoma in a case-control study. J Oral Pathol Med 2015;44(4):252—7. DOI: doi.org/10.1111/jop.12231.
17. Jalouli J., Jalouli M.M., Sapkota D. et al. Human papilloma virus, herpes simplex virus and Epstein—Barr virus in oral squamous cell carcinoma from eight different countries. Anticancer Res 2012;32(2):571—80. DOI: 0250-7005/2012.
18. Deng Z., Uehara T., Maeda H. et al. Epstein—Barr virus and human papillomavirus infections and genotype distribution in head and neck cancers. PLoS One 2014;9(11):e113702. DOI: 10.1371/journal.pone.0113702.
19. Elgui de Oliveira D. DNA viruses in human cancer: an integrated overview on fundamental mechanisms of viral carcinogenesis. Cancer Lett 2007;247(2):182—96. DOI: 10.1016/j.canlet.2006.05.010.
20. Rickinson A.B. Co-infections, inflammation and oncogenesis: future directions for EBV research. Semin Cancer Biol 2014;26:99—115. DOI: 10.1016/j.semcancer.2014.04.004.
21. Plummer M., de Martel C., Vignat J. et al. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health 2016;4(9):e609—16. DOI: 10.1016/S2214-109X(16)30143-7.
22. Zur Hausen H. Novel human polyomaviruses — re-emergence of a well known virus family as possible human carcinogens. Int J Cancer 2008;123(2):247—50. DOI: 10.1002/ijc.23620.
23. World Health Organization, International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 90. Human papillomaviruses. Lyon: World Health Organization, 2007. 689 p. Available at: https://monographs.iarc.fr/wp-content/uploads/2018/06/mono90.pdf.
24. Gillison M.L., Koch W.M., Capone R.B. et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92(9):709—20. DOI: 10.1093/jnci/92.9.709.
25. Ang K.K., Harris J., Wheeler R. et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363(1):24—35. DOI: 10.1056/NEJMoa0912217.
26. Sekee T.R., Burt FJ., Goedhals D. et al. Human papillomavirus in head and neck squamous cell carcinomas in a South African cohort. Papillomavirus Res 2018;6:58-62. DOI: 10.1016/j.pvr.2018.10.006.
27. Bahl A., Kumar P., Dar L. et al. Prevalence and trends of human papillomavirus in oropharyngeal cancer in a predominantly north Indian population. Head Neck 2014;36(4):505—10. DOI: 10.1002/hed.23317.
28. Huang C.-G., Lee L.-A., Fang T.-J. et al. Human papillomavirus infection is not associated with laryngeal squamous cell carcinoma in Taiwan. J Microbiol Immunol Infect 2018 Feb 21. DOI: 10.1016/j.jmii.2018.02.002.
29. Rodrigo J.P., Hermsen M.A., Fresno M.F. et al. Prevalence of human papillomavirus in laryngeal and hypopharyngeal squamous cell carcinomas in northern Spain. Cancer Epidemiol 2015;39(1):37—41. DOI: 10.1016/j.canep.2014.11.003.
30. Shaikh M.H., Khan A.I., Sadat A. et al. Prevalence and types of high-risk human papillomaviruses in head and neck cancers from Bangladesh. BMC Cancer 2017;17(1):729. DOI: 10.1186/s12885-017-3789-0.
31. Tan L.S., Fredrik P., Ker L. et al. High-risk HPV genotypes and P16INK4a expression in a cohort of head and neck squamous cell carcinoma patients in Singapore. Oncotarget 2016;7(52):86730—9. DOI: 10.18632/oncotarget.13502.
32. Glombitza F., Guntinas-Lichius O., Petersen I. HPV status in head and neck tumors. Pathol Res Pract 2010;206(4): 229—34. DOI: 10.1016/j.prp.2009.11.007.
33. Major T., Szarka K., Sziklai I. et al. The characteristics of human papillomavirus DNA in head and neck cancers and papillomas. J Clin Pathol 2005;58(1):51—5. DOI: 10.1136/jcp.2004.016634.
34. Antonsson A., Neale R.E., Boros S. et al. Human papillomavirus status and p16(INK4A) expression in patients with mucosal squamous cell carcinoma of the head and neck in Queensland, Australia. Cancer Epidemiol 2015;39(2):174—81. DOI: 10.1016/j.canep.2015.01.010.
35. Adamopoulou M., Vairaktaris E., Panis V. et al. HPV detection rate in saliva may depend on the immune system efficiency. In Vivo 2008;22(5):599—602. DOI: 0258-851X/2008.
36. Anderson C.E., McLaren K.M., Rae F. et al. Human papilloma virus in squamous carcinoma of the head and neck: a study of cases in south east Scotland. J Clin Pathol 2007;60(4):439—41. DOI: 10.1136/jcp.2005.033258.
37. Koyama K., Uobe K., Tanaka A. Highly sensitive detection of HPV-DNA in paraffin sections of human oral carcinomas. J Oral Pathol Med 2007;36(1):18—24. DOI: 10.1111/j.1600-0714.2006.00490.x.
38. Sugiyama M., Bhawal U.K., Kawamura M. et al. Human papillomavirus-16 in oral squamous cell carcinoma: clinical correlates and 5-year survival. Br J Oral Maxillofac Surg 2007;45(2):116—22. DOI: 10.1016/j.bjoms.2006.04.012.
39. Ritchie J.M., Smith E.M., Summers-gill K.F. et al. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 2003;104(3): 336—44. DOI: 10.1002/ijc.10960.
40. Kansky A.A., Poljak M., Seme K. et al. Human papillomavirus DNA in oral squamous cell carcinomas and normal oral mucosa. Acta Virol 2003;47(1):11—6.
41. St. Guily J.L., Jacquard A.-C., Pretet J.-L. et al. Human papillomavirus genotype distribution in oropharynx and oral cavity cancer in France — the EDiTH VI study. J Clin Virol 2011;51(2):100—4. DOI: 10.1016/j.jcv.2011.03.003.
42. Morshed K., Polz-Dacewicz M., Szymanski M., Polz D. Short-fragment PCR assay for highly sensitive broad-spectrum detection of human papillomaviruses in laryngeal squamous cell carcinoma and normal mucosa: clinico-pathological evaluation. Eur Arch Otorhinolaryngol 2008;265 Suppl 1:S89—96. DOI: 10.1007/s00405-007-0569-5.
43. Nemes J.A., Deli L., Nemes Z., Marton I.J. Expression of p16 (INK4A), p53, and Rb proteins are independent from the presence of human papillomavirus genes in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102(3):344—52. DOI: 10.1016/j.tripleo.2005.10.069.
44. Herrero R., Castellsague X., Pawlita M. et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003;95(23):1772—83. DOI: 10.1093/jnci/djg107.
45. Scapoli L., Palmieri A., Rubini C. et al. Low prevalence of human papillomavirus in squamous-cell carcinoma limited to oral cavity proper. Mod Pathol 2009;22(3):366—72. DOI: 10.1038/modpathol.2008.180.
46. Villagomez-Ortiz V.J., Paz-Delgadillo D.E., Marino-Martinez I. et al. [Prevalence of human papillomavirus infection in squamous cell carcinoma of the oral cavity, oropharynx and larynx (In Spanish)]. Cir Cir 2016;84(5):363—8. DOI: 10.1016/j.circir.2016.01.006.
47. Xu Y., Liu S., Yi H. et al. Low prevalence of human papillomavirus in head and neck squamous cell carcinoma in Chinese patients. J Med Virol 2015;87(2):281—6. DOI: 10.1002/jmv.24052.
48. Bogatov V.V., Chervinets V.M., Samoukina A.M. et al. Role of viruses with oncogenic potential and their associations in oncogenesis in maxillofacial area. Stomatologiya = Stomatology 2015;94(1):23—4. (In Russ.).
Review
For citations:
Pevzner A.M., Tsyganov M.M., Ibragimova M.K., Litvyakov N.V. Human papillomavirus in head and neck cancer (literature review). Head and Neck Tumors (HNT). 2019;9(2):43-52. (In Russ.) https://doi.org/10.17650/2222-1468-2019-9-2-43-52
Views:
1538
Email this article 